Credit Suisse’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $3.07M | Buy |
28,624
+156
| +0.5% | +$15.5K | ﹤0.01% | 1591 |
|
|
2023
Q4 | $2.84M | Sell |
28,468
-2,082
| -7% | -$204K | ﹤0.01% | 1683 |
|
|
2023
Q3 | $3.64M | Sell |
30,550
-555
| -2% | -$82.8K | ﹤0.01% | 1469 |
|
|
2023
Q2 | $5.54M | Buy |
31,105
+7,936
| +34% | +$1.46M | 0.01% | 1275 |
|
|
2023
Q1 | $3.82M | Buy |
23,169
+874
| +4% | +$150K | ﹤0.01% | 1494 |
|
|
2022
Q4 | $3.51M | Buy |
22,295
+852
| +4% | +$130K | ﹤0.01% | 1541 |
|
|
2022
Q3 | $3.23M | Buy |
21,443
+87
| +0.4% | +$14.5K | ﹤0.01% | 1526 |
|
|
2022
Q2 | $3.51M | Sell |
21,356
-507
| -2% | -$97.6K | ﹤0.01% | 1532 |
|
|
2022
Q1 | $4.87M | Buy |
21,863
+802
| +4% | +$180K | ﹤0.01% | 1461 |
|
|
2021
Q4 | $5M | Sell |
21,061
-3,029
| -13% | -$708K | ﹤0.01% | 2021 |
|
|
2021
Q3 | $5.62M | Buy |
24,090
+1,162
| +5% | +$244K | ﹤0.01% | 1954 |
|
|
2021
Q2 | $4.72M | Sell |
22,928
-4,769
| -17% | -$981K | ﹤0.01% | 2127 |
|
|
2021
Q1 | $5.69M | Buy |
27,697
+725
| +3% | +$153K | ﹤0.01% | 1973 |
|
|
2020
Q4 | $5.79M | Buy |
26,972
+6,597
| +32% | +$1.28M | ﹤0.01% | 1976 |
|
|
2020
Q3 | $3.72M | Sell |
20,375
-503
| -2% | -$94.7K | ﹤0.01% | 1983 |
|
|
2020
Q2 | $3.85M | Buy |
20,878
+1,848
| +10% | +$367K | ﹤0.01% | 1886 |
|
|
2020
Q1 | $3.84M | Buy |
19,030
+1,089
| +6% | +$210K | ﹤0.01% | 1705 |
|
|
2019
Q4 | $3.36M | Sell |
17,941
-6,474
| -27% | -$1.11M | ﹤0.01% | 2189 |
|
|
2019
Q3 | $3.9M | Buy |
24,415
+9,956
| +69% | +$1.98M | ﹤0.01% | 1960 |
|
|
2019
Q2 | $3.64M | Sell |
14,459
-1,553
| -10% | -$360K | ﹤0.01% | 1999 |
|
|
2019
Q1 | $3.83M | Buy |
16,012
+3,331
| +26% | +$799K | ﹤0.01% | 1924 |
|
|
2018
Q4 | $2.91M | Sell |
12,681
-19,878
| -61% | -$4.9M | ﹤0.01% | 1970 |
|
|
2018
Q3 | $9.21M | Buy |
32,559
+464
| +1% | +$136K | 0.01% | 1306 |
|
|
2018
Q2 | $9.43M | Buy |
32,095
+13,801
| +75% | +$3.77M | 0.01% | 1276 |
|
|
2018
Q1 | $4.62M | Buy |
18,294
+4,537
| +33% | +$1.07M | ﹤0.01% | 1763 |
|
|
2017
Q4 | $2.97M | Sell |
13,757
-3,711
| -21% | -$751K | ﹤0.01% | 2134 |
|
|
2017
Q3 | $3.25M | Buy |
17,468
+9,171
| +111% | +$1.6M | ﹤0.01% | 2139 |
|
|
2017
Q2 | $1.43M | Sell |
8,297
-5,300
| -39% | -$850K | ﹤0.01% | 2454 |
|
|
2017
Q1 | $2.08M | Sell |
13,597
-8,367
| -38% | -$1.22M | ﹤0.01% | 2328 |
|
|
2016
Q4 | $3.24M | Buy |
21,964
+1,673
| +8% | +$242K | ﹤0.01% | 2024 |
|
|
2016
Q3 | $2.56M | Buy |
20,291
+7,001
| +53% | +$844K | ﹤0.01% | 2196 |
|
|
2016
Q2 | $1.5M | Buy |
13,290
+7,894
| +146% | +$819K | ﹤0.01% | 2574 |
|
|
2016
Q1 | $562K | Sell |
5,396
-2,632
| -33% | -$252K | ﹤0.01% | 3168 |
|
|
2015
Q4 | $906K | Sell |
8,028
-8,455
| -51% | -$934K | ﹤0.01% | 2890 |
|
|
2015
Q3 | $1.8M | Sell |
16,483
-6,975
| -30% | -$746K | ﹤0.01% | 2333 |
|
|
2015
Q2 | $2.24M | Buy |
23,458
+5,913
| +34% | +$553K | ﹤0.01% | 2464 |
|
|
2015
Q1 | $1.63M | Sell |
17,545
-38,957
| -69% | -$3.41M | ﹤0.01% | 2557 |
|
|
2014
Q4 | $4.63M | Buy |
56,502
+30,810
| +120% | +$2.36M | ﹤0.01% | 1824 |
|
|
2014
Q3 | $1.65M | Buy |
25,692
+56
| +0.2% | +$3.43K | ﹤0.01% | 2645 |
|
|
2014
Q2 | $1.56M | Buy |
25,636
+12,697
| +98% | +$750K | ﹤0.01% | 2923 |
|
|
2014
Q1 | $774K | Sell |
12,939
-13,284
| -51% | -$818K | ﹤0.01% | 3349 |
|
|
2013
Q4 | $1.67M | Buy |
26,223
+9,469
| +57% | +$609K | ﹤0.01% | 2828 |
|
|
2013
Q3 | $1.14M | Buy |
16,754
+7,762
| +86% | +$554K | ﹤0.01% | 2846 |
|
|
2013
Q2 | $648K | Buy |
+8,992
| New | +$595K | ﹤0.01% | 3122 |
|
Other funds holding ICUI
Credit Suisse's ICUI Position: Q1 2024 in Review
Credit Suisse increased its ICU Medical (ICUI) stake by 0.55% in Q1 2024, buying an estimated $15.5K and bringing the position to 28,624 shares worth $3.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1591.
Credit Suisse first reported a position in ICUI in Q2 2013 and has held it in 44 quarters since. The position peaked at $9.43M in Q2 2018. 252 funds tracked by Wall St. Rank hold ICUI as of Q1 2024.
- Credit Suisse held 28,624 shares of ICU Medical worth $3.07M as of Q1 2024.
- Credit Suisse bought 156 ICU Medical shares in Q1 2024, an estimated $15.5K.
- ICU Medical made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1591 holding.
- Credit Suisse first reported a position in ICU Medical in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's ICU Medical position peaked at $9.43M in Q2 2018.
- 252 funds tracked by Wall St. Rank held ICU Medical as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.